Cases & Deals

  • Home
  • Practices
  • Primrose Bio develops global patent portfolios for engineered enzymes and manufacturing technologies for human therapeutics

Share

Primrose Bio develops global patent portfolios for engineered enzymes and manufacturing technologies for human therapeutics

August 2025

Client(s) Primrose Bio, Inc.

Jones Day is representing Primrose Bio, Inc. in the establishment of global patent portfolios related to the development and commercialization of proprietary, integrated technology platforms and high-efficiency production systems for complex biologics, leveraging advanced protein expression and enzyme engineering to solve drug manufacturing and design challenges and deliver improved enzymes and high-yield manufacturing technologies for next-generation therapeutics, including mRNA medicines.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.